A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population
about
sameAs
Genetic variants in TNFa, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthmaVariability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectivesPolymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approachInfluence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.PharmGKB summary: very important pharmacogene information for PTGS2.Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern IndiaAssociation of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study.Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients.Cyclooxygenase-2 gene and lung carcinoma risk.COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of ?765G>C with disease risk
P2860
Q23910400-59B019D1-968D-447E-8573-AE4076E117DCQ27012539-7B7BB517-53B8-4A06-B715-2F7CFEFD41EFQ28199903-EAB89374-B430-4B28-92C3-6ADE082565ECQ33584246-8B2F3BA1-B482-4936-A264-93C3BF22EC9DQ33869492-5AF36366-211E-426D-BD08-31E4B7CA385CQ34096844-0E895B15-BD8F-49DD-A415-A5DF2AEE459DQ35120350-5B160F12-7C64-422D-8DC9-A1A41E8F9B22Q37220827-FB38845C-541B-461E-B409-15C740717179Q37235517-61CDD7EE-0A7B-47E2-AFD9-AA93C1583081Q42736023-D462101E-D93E-4814-8E71-52FC429FECD1Q46588700-ED760206-7003-40BB-ACB0-180C1C68F624Q48855054-109F485D-07D1-4848-8342-BB1BCB3299AFQ54419033-EBE19DC6-0B5B-4596-90D2-60D868B0C73FQ58885887-EC4F7944-62FC-4B6A-AF82-D8005F5ECBD4
P2860
A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A functional polymorphism in t ...... py in an Australian population
@ast
A functional polymorphism in t ...... py in an Australian population
@en
A functional polymorphism in t ...... py in an Australian population
@nl
type
label
A functional polymorphism in t ...... py in an Australian population
@ast
A functional polymorphism in t ...... py in an Australian population
@en
A functional polymorphism in t ...... py in an Australian population
@nl
prefLabel
A functional polymorphism in t ...... py in an Australian population
@ast
A functional polymorphism in t ...... py in an Australian population
@en
A functional polymorphism in t ...... py in an Australian population
@nl
P2093
P2860
P1476
A functional polymorphism in t ...... py in an Australian population
@en
P2093
P2860
P304
P356
10.1111/J.1365-2222.2004.02094.X
P407
P50
P577
2004-11-01T00:00:00Z